SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as crude rises amid escalating Middle East tensions and concerns that renewed conflict or attacks on Gulf energy and shipping could disrupt supply. Traders are split between riding the breakout and warning that de-escalation headlines or stretched momentum could bring a sharp pullback.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Ciphers steep selloff is the dominant topic, with traders blaming the recent share offering and dilution overhang alongside weakness across AI and data-center stocks; concerns about financing, management communication, and the upcoming earnings report add pressure. Bulls argue its contracted AI/HPC business and remaining project pipeline support a long-term case, while skeptics question execution and whether the stock has found a floor.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

SpaceXs push toward a nationwide wireless serviceincluding reported plans to access cell siteshas fueled a sharp selloff in AT&T and other carriers. Traders are split between viewing the move as a serious long-term competitive threat and calling the reaction overblown because building a competing network could take years; many are buying the dip for AT&Ts recurring business and dividend.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

MaxLinears plan to target a share of the 1.6T active electrical cable market has pressured Credo shares, with traders debating whether the competitive threat outweighs Credos current market lead. Some see the sharp selloff as an overreaction given expectations for rapid AEC demand growth, while others remain concerned about further downside.

Maplebear, Inc. engages in the design and development of an online application that offers grocery delivery and pick-up services. The firm offers Instacart which enables users to connect with personal shoppers in the area who pick up and deliver groceries from local stores. The company was founded by Apoorva Mehta, Brandon Leonardo, and Max Mullen in 2012 and is headquartered in San Francisco, CA.

Maplebear Inc.

Instacart

Reports that Instacart is exploring a sale and held preliminary talks with DoorDash and Uber are driving attention, with traders speculating about a potential takeover premium. The discussion treats a deal as possible rather than confirmed, alongside bullish calls and momentum chatter.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is drawing attention for sharp, volatile trading and persistent underperformance versus Bitcoin and other crypto-linked stocks, with traders questioning why shares often lag when crypto rebounds. The debate is split between bearish concerns about further downside and dip-buying ahead of the upcoming quarterly report or a broader crypto recovery.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

CleanSpark is drawing attention after a steep selloff alongside other Bitcoin miners and AI/data-center infrastructure stocks, with traders citing sector weakness, higher-rate and financing concerns, and frustration that shares have fallen despite Bitcoin strength. The community is split between shorting the downtrend and buying what some view as oversold levels, with others pointing to the Meta data-center lease as a longer-term bullish counterpoint.

Icahn Enterprises LP is a holding company. It operates through the following segments: Investment, Automotive, Energy, Food Packaging, Real Estate, Home Fashion, Pharma, and Holding Company. The Investment segment consists of various private investment funds. The Automotive segment holds ownership in Icahn Automotive Group, LLC. The Energy segment refers to petroleum refining and marketing businesses. The Food Packaging segment involves the production and sale of cellulosic, fibrous, and plastic casings for the processed meat and poultry industry. The Real Estate segment offers rental real estate, property development, and resort activities. The Home Fashion segment deals with manufacturing, sourcing, marketing, distributing, and selling home fashion consumer products. The Pharma segments operate through Vivus, Inc., a specialized pharmaceutical company. The Holding Company segment manages acquisition and investment in operating businesses. The company was founded on February 17, 1987 and is headquartered in Sunny Isles Beach, FL.

Icahn Enterprises L P - Unit

Icahn Enterprises, L.P.

IEPs continued selloff is fueling debate over whether heavy short interest is adding pressure or whether investors are reacting to concerns about the sustainability of its distribution, dilution, and Icahn Enterprises performance. Some traders anticipate a short squeeze or a rebound tied to its CVR Energy stake, while others expect further weakness and are looking to upcoming earnings for clarity.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Ubers agreement to acquire workplace-catering platform ezCater is drawing attention as a move to expand Uber Eats into corporate and group orders. Some traders view the deal as diversification and a growth opportunity, while others question the acquisition strategy and remain frustrated by the stocks weak price action.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

Golds extended decline and concerns that persistent inflation could keep interest rates higher are weighing on GDX, whose gold-miner holdings can amplify moves in the metal. Traders are split between buying the pullback near support and expecting further downside if gold weakens further.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: $LABT ) is presenting research on the in vitro antimicrobial profile of Nu-3, the company&#39;s lead clinical candidate, at IDWeek 2026, taking place October 21-24, 2026, in Washington, D.C. The poster is in the Novel Agents session on October 22 from 12:15 to 1:30 PM ET in Poster Hall B-C. 
 
Lakewood-Amedex Biotherapeutics Inc. is a B2i Digital Featured Company. See the company&#39;s in-depth profile at: https://b2idigital.com/lakewood-amedex-biotherapeutics-inc-1 
 
The poster&#39;s in vitro data demonstrate broad-spectrum and rapid bactericidal activity for Nu-3, along with a favorable resistance profile in serial-passage testing: 
 
• Bactericidal activity against Gram-positive, Gram-negative and multidrug-resistant bacteria 
• Bacterial eradication occurring within minutes for tested pathogens, as well as activity against biofilm organisms 
• Only a slight increase in minimum inhibitory concentration (MIC) values against Staphylococcus aureus and Escherichia coli, compared with a 600- to 2,000-fold increase for ciprofloxacin  
&quot;The data being presented at IDWeek reinforce the potential of Nu-3 to play an important role in addressing the growing threat of antimicrobial resistance,&quot; said Chief Executive Officer Kelvin Cooper, Ph.D. 
 
Read the full release: https://lakewoodamedex.investorroom.com/2026-10-21-Lakewood-Amedex-Biotherapeutics-Presents-Data-Highlighting-Nu-3s-Broad-Spectrum-Antimicrobial-Activity-and-Low-Potential-for-Resistance-at-IDWeek-2026 
 
These findings are relevant to infected diabetic foot ulcer (iDFU), where approximately half of diabetic foot ulcers become infected and an estimated 15% to 25% involve resistant organisms, primarily methicillin-resistant Staphylococcus aureus (MRSA). Nu-3 is currently being investigated in an ongoing Phase 2a clinical trial in patients with infected diabetic foot ulcers, with topline data expected in the first quarter of 2027. 
 
Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) is a clinical-stage biotechnology Company developing a novel class of fast-acting, broad-spectrum antimicrobials, the Bisphosphocin® class, to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. For more information, please visit https://lakewoodamedex.com. 
 
Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. 
 
David Shapiro, Chief Executive Officer of B2i Digital, personally purchased in the open market and currently owns shares of unrestricted LABT stock, in line with B2i Digital’s practice of investing alongside its Featured Companies. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://b2idigital.com/disclaimer. 
 
$SPRO, $CDTX, $SCYX, $XBI

BioSwings™

David Shapiro

Congratulations

Den Tongco

Canesn83

Linda Scott

Bonnie Siegmund

Craig Salinas

Ariana Storck

Roberta Creech

Henry Callaghan

Michael Musto

Eugene Davenport

John Park

Melissa Vermillion

Shirley Hall

James Adair

Kelly Distaffen

Renee Blankenship

Jeanne Hodges

Micheal Fikes

Nina Studdard

Raymond Oliver

Filomena Marsh

Lucy Pena

Amber Reilly

Karen Paris

Terry Skora

Lillian Ellis

Edwina Packard

b2i digital - connecting companies and investors through digital marketing, investor conferences, and direct introductions and meetings.

B2idigital

B2i Digital - Connecting companies and investors

Disclaimer - Content is provided "as is" by companies featured on the site. Conduct a trusted advisory before making investments.

Disclaimer - Consult an advisor before making any investments

Lakewood-Amedex Biotherapeutics (NASDAQ: LABT) is a clinical-stage biotech developing Bisphosphocin antimicrobials to fight drug-resistant infections.

Lakewood-Amedex Biotherapeutics Inc. | Nasdaq: LABT

Our novel approach fights infections with highly effective Bisphosphocins® directly at the site of infection. Bisphosphocins® directly disrupt microbial membranes, leading to fast eradication of infections.

Lakewoodamedex

Lakewood Amedex Biotherapeutics | Lakewood-Amedex Biotherapeutics | DEVELOPING SOLUTIONS FOR ANTIBIOTIC RESISTANCE CRISIS

Research highlights Nu-3's rapid bactericidal activity against clinically relevant resistant pathogens and its potential as a topical treatment for infected diabetic foot ulcers SARASOTA, Fla.,...

Lakewood-Amedex Biotherapeutics Investors

Lakewood-Amedex Biotherapeutics Presents Data Highlighting Nu-3's Broad-Spectrum Antimicrobial Activity and Low Potential for Resistance at IDWeek 2026

StockTwits Web

Lakewood-Amedex Biotherapeutics Inc.

Spero Therapeutics Inc

Cidara Therapeutics Inc

Scynexis Inc

SPDR S&P Biotech ETF

Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: 

 ) is presenting research on the in vitro antimicrobial profile of Nu-3, the company's lead clinical candidate, at IDWeek 2026, taking place October 21-24, 2026, in Washington, D.C. The poster is in the Novel Agents session on October 22 from 12:15 to 1:30 PM ET in Poster Hall B-C. 
 
Lakewood-Amedex Biotherapeutics Inc. is a B2i Digital Featured Company. See the company's in-depth profile at: https://

/lakewood-amedex-biotherapeutics-inc-1 
 
The poster's in vitro data demonstrate broad-spectrum and rapid bactericidal activity for Nu-3, along with a favorable resistance profile in serial-passage testing: 
 
• Bactericidal activity against Gram-positive, Gram-negative and multidrug-resistant bacteria 
• Bacterial eradication occurring within minutes for tested pathogens, as well as activity against biofilm organisms 
• Only a slight increase in minimum inhibitory concentration (MIC) values against Staphylococcus aureus and Escherichia coli, compared with a 600- to 2,000-fold increase for ciprofloxacin  
"The data being presented at IDWeek reinforce the potential of Nu-3 to play an important role in addressing the growing threat of antimicrobial resistance," said Chief Executive Officer Kelvin Cooper, Ph.D. 
 
Read the full release: 

 
 
These findings are relevant to infected diabetic foot ulcer (iDFU), where approximately half of diabetic foot ulcers become infected and an estimated 15% to 25% involve resistant organisms, primarily methicillin-resistant Staphylococcus aureus (MRSA). Nu-3 is currently being investigated in an ongoing Phase 2a clinical trial in patients with infected diabetic foot ulcers, with topline data expected in the first quarter of 2027. 
 
Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) is a clinical-stage biotechnology Company developing a novel class of fast-acting, broad-spectrum antimicrobials, the Bisphosphocin® class, to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. For more information, please visit 

. 
 
Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at 

. 
 
David Shapiro, Chief Executive Officer of B2i Digital, personally purchased in the open market and currently owns shares of unrestricted LABT stock, in line with B2i Digital’s practice of investing alongside its Featured Companies. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://

Lakewood-Amedex Biotherapeutics Inc. is presenting promising Nu-3 research at IDWeek 2026, highlighting rapid, broad-spectrum antimicrobial activity and low potential for resistance. With antibiotic resistance a growing concern, these findings could be important for future treatment options. 
Learn more about this B2i Digital Featured Company profile at: https://b2idigital.com/lakewood-amedex-biotherapeutics-inc-1

Lakewood-Amedex Biotherapeutics Inc. is presenting promising Nu-3 research at IDWeek 2026, highlighting rapid, broad-spectrum antimicrobial activity and low potential for resistance. With antibiotic resistance a growing concern, these findings could be important for future treatment options. 
Learn more about this B2i Digital Featured Company profile at: 

@B2iDigital Why are you spamming the Scynexis page?  Can you F off?

 Why are you spamming the Scynexis page?  Can you F off?